Íris Pétursdóttir

Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir, Elín Ruth Reed et autres

Authors and Affiliations Faculty of Medicine, Univeristy of Iceland, Reykjavík, Iceland Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, Elín Ruth Reed, Jón Þórir Óskarsson, Íris Pétursdóttir, Guðrún Ásta Sigurðardóttir, Páll Torfi Önundarson, Bjarni A. Agnarsson, Ásdís Rósa Þórðardóttir, Gunnar Þór Gunnarsson, Runólfur …

is, dk, us (code pays fourni par la source)

OAB-037: Detection of abnormal plasma cells by multiparameter flow cytometry in a screened cohort of patients with monoclonal gammopathy of undetermined significance

Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir, Íris Pétursdóttir et autres

Prevalence of Smoldering Multiple Myeloma: Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson et autres

Abstract Background Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition to multiple myeloma (MM). Emerging data from clinical trials indicate that - compared to watchful monitoring - initiation of therapy at the SMM stage might be indicated. Currently, there is no …

is, dk, us (code pays fourni par la source)

Monitoring of Circulating Tumor Plasma Cells in Patients with Precursor Conditions of Multiple Myeloma: Data from the Prospective Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

Jón Þórir Óskarsson, Íris Pétursdóttir, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir et autres

Abstract Background: A proportion of patient with monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) will progress to active multiple myeloma (MM). Optimization of follow-up strategies and diagnostic testing is needed to detect those who are at risk of …

is, dk, us (code pays fourni par la source)

Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

Sigurður Y. Kristinsson, Sæmundur Rögnvaldsson, Sigrún Þorsteinsdóttir, Elín Ruth Reed et autres

Abstract Background: Cancer screening is performed worldwide for several malignancies. Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma (MM) and related lymphoproliferative disorders (LP). However, less than 5% of all MM patients are diagnosed during their precursor state and individuals who …

is, dk, sk, us (code pays fourni par la source)

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir, Elín Ruth Reed et autres

Monoclonal gammopathy of undetermined significance (MGUS) precedes multiple myeloma (MM). Population-based screening for MGUS could identify candidates for early treatment in MM. Here we describe the Iceland Screens, Treats, or Prevents Multiple Myeloma study (iStopMM), the first population-based screening study for MGUS …

is, dk, us (code pays fourni par la source)

Áhrif æðaþels, húðfruma og D- vítamíns á tjáningu húðsækinna ratvísissameinda á yfirborði T- fruma

Íris Pétursdóttir

4 Þakkir 5 Efnisyfirlit 6 Myndaskra 8 Tofluskra 8 Listi yfir skammstafanir 9 1 Inngangur 10 1.1 Onaemissvar huðar 10 1.2 Tfrumur 12 1.3 Ratvisi Tfruma 15 1.4 Dvitamin 16 1.5 Psoriasis 17 1.6 Frumuraektunarmodelið 17 2 Markmið 19 3 Efni og …